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Abstract. The World Health Organization recommends exclusive breastfeeding (EBF) for the first 6 months of life.
However, the effect of EBF on malaria risk remains unclear. In the present study, 137 EBF infants and 358 non-EBF
infants from the Democratic Republic of the Congo were assessed for fever and malaria infections by polymerase chain
reaction, at 6 months of age. EBF was associated with a reduced risk of clinical malaria (odds ratio = 0.13; 95% confi-
dence interval = 0.00–0.80), suggesting a protective effect of EBF against malaria.
INTRODUCTION
In 2013, more than 80% of the world’s malaria cases
and malaria-related deaths occurred in the World Health
Organization (WHO) African region.1 Most of these deaths
occurred in children under the age of 5 years, who lack natu-
rally acquired immunity (NAI) and as a consequence have
the highest rates of infection, complications, and mortality.1,2
However, despite lacking NAI, the first months of life are
marked by a low incidence of clinical malaria.2,3 The low
incidence of clinical malaria among infants has been hypoth-
esized to be due to transplacental transfer of protective mater-
nal immunoglobulin G (IgG),4 although other studies have
not supported these findings.3
Similarly, the effect of breastfeeding on malaria risk dur-
ing the first months of life remains uncertain. Recent stud-
ies found increased malaria prevalence among exclusively
breastfed infants in Uganda and Malawi, whereas a study
conducted in Nigeria found a decreased prevalence.5–7 Despite
the different prevalence findings, all three studies suggested
that exclusive breastfeeding (EBF) had no significant effect
on malaria infection risk.5–7 However, the study from Nigeria
was based on questionnaires and is subject to recall bias,
whereas the Malawian study did not use the proper EBF
definition as proposed by the WHO.7,8 These conflicting
results need to be resolved, as the WHO recommends that
all mothers EBF for the first 6 months in recognition of EBF
benefits for infants.9–11 We sought to determine whether EBF
affected the susceptibility to malaria infection and clinical
malaria in a cohort of EBF and non-EBF infants residing in
Kinshasa, Democratic Republic of the Congo.
METHODS
This cross-sectional study was conducted as an ancillary
study to a randomized trial designed to evaluate breast-
feeding promotion interventions (Yotebieng and others12).
The study took place in Kinshasa, the Democratic Repub-
lic of the Congo, in six health facilities (Esengo, Kikenda,
Kitega, Libikisi, Lukunga, and Luyindu). All mothers who
birthed a healthy singleton during the enrollment period
(May 24–August 25, 2012) and intended to attend well-baby
clinic visits in the same facility were eligible for the original
trial. Written consent and dried blood spots (DBS) were
collected during the 24-week study visit using Whatman™
filter paper (GE Healthcare Bio-Sciences, Pittsburgh, PA)
and shipped to the University of North Carolina at Chapel
Hill for laboratory testing. Of 975 infants, 855 enrolled in the
parent study were seen at the 24-week visit. However, due to
limited supplies, DBS samples were collected for only 495
infants. The human immunodeficiency virus (HIV) status
for 480/495 mothers was obtained from the Prevention of
Mother-to-Child Transmission registry.
From each patient’s DBS card, genomic DNA (gDNA) was
extracted as previously described.13 The samples were then
evaluated using real-time polymerase chain reaction (PCR)
with each well containing 2 μL of extracted gDNA, 6.25 μL of
FastStart Universal Probe Master (Rox; Roche Diagnostics,
Indianapolis, IN), 155 nL of 20 μM forward and reverse Plas-
modium falciparum lactate dehydrogenase (PfLDH) primer,
190 nL of 20 μM PfLDH TaqMan® Probe (Applied Bio-
systems, Thermo Fisher Scientific, Waltham, MA), and 3.25 μL
of molecular-grade water. All plates included a negative con-
trol and five positive controls (P. falciparum DNA) at sequen-
tial log concentrations ranging from 10−2 to 10−5 ng/μL.
Samples were considered positive if they had a Ct of < 38
or two Ct values of < 39 using the Bio-Rad CFX384
™ Real-
Time PCR Detection system (Bio-Rad, Clinical Diagnostics,
Hercules, CA). Positive samples in the first series or indeter-
minates were evaluated in duplicate or, if necessary, triplicate
using increased concentrations of gDNA (4 μL).
Information on infant feeding was collected through a face-
to-face interview during the 24-week visit. Infants were clas-
sified as being exclusively breastfed using the definitions
proposed by the WHO14 and recall of the past 24 hours and
past 7-day time frames. In addition, mothers were asked during
the 24-week interview whether their infant had experienced
any fever or had consumed any medications during the month
preceding the interview. Mothers were also asked if their infant
had slept under a bed net the night preceding the interview.
Malaria microscopy was not performed during the 24-week
clinical visit and infant’s temperatures were not recorded.
The two outcomes of interest for the analysis were malaria
infection, which was defined by a positive PCR (since micros-
copy was not performed), and clinical malaria, which
was defined as a positive PCR and reported fever. Other
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variables considered in the analysis were related to the
mother’s sociodemographic characteristics (Table 1).
Associations between potential confounders and the out-
comes were assessed using Fisher’s exact test or χ2 test,
when appropriate, for categorical variables and Wilcoxon
rank sum test for continuous variables. Simple and stratified
exact Cochran–Mantel–Haenszel odds ratios (ORs) and 95%
confidence intervals (95% CIs) were used to assess the
strength of the association between EBF and the two out-
comes of interest. Analyses were performed using SAS®9.3
(Cary, NC) and assessed at a 0.05 significance level.
RESULTS
At the 24-week interview time point, 137 (27.7%) of the
infants were EBF. First-time mothers (primiparous) and
younger mothers (median = 27; interquartile range = 22.0–
32.0) were less likely to exclusively breastfeed (P = 0.0078
and P = 0.0141, respectively). In addition, EBF infants were
more likely to have used bed nets (P < 0.0001) but less likely
to have used antimalarials (P = 0.0439).
Malaria parasitemia was confirmed by PCR in 52 (10.5%)
infants, of whom, 21 were reported to have had a fever in
the last month. In bivariate analyses, EBF was associated
with a slight, but not significant, reduced risk of malaria
infection (prevalence of 9.5% versus 10.9%; OR = 0.82; 95%
CI = 0.39–1.62). EBF significantly reduced the risk of clinical
malaria (OR = 0.13; 95% CI = 0.00–0.80). Indeed, only one
(0.7%) case of clinical malaria was in an EBF infant. Bed
net use was associated with reduced risk of malaria infection
(OR = 0.63; 95% CI = 0.34–1.19) and clinical malaria (OR =
0.41; 95% CI = 0.15–1.09). The reported use of antimalarial
drugs was associated with increased risk of malaria infection
(OR = 1.76; 95% CI = 0.71–3.97) and clinical malaria (OR =
6.81; 95% CI = 2.39–18.57). Maternal parity appeared to have
little, if any, effect on the rate of malaria infection or clinical
malaria (Table 1).
Among the infants without malaria infections, 116 (26.19%)
presented with fever. EBF was found to be protective against
fever among infants with and without malaria infection (OR =
0.08; 95% CI = 0.01–0.67 and OR = 0.74; 95% CI = 0.432–
1.23, respectively).
In stratified analyses, among children who used bed nets,
10 (9.3%) EBF and eight (8.7%) non-EBF infants presented
with malaria infection (OR = 1.07; 95% CI = 0.42–2.56;
Table 2). Among non-bed net users, malaria infection was
found in three EBF (10.3%) and 21 non-EBF (13.9%)
infants (OR = 0.71; 95% CI = 0.12–2.67). Overall, controlling
for bed net use, there was a tendency toward lower odds of
malaria infection among EBF infants (OR = 0.86; 95% CI =
0.41–1.71), although these associations lacked statistical
significance. For clinical malaria, among bed net users, one
(0.9%) EBF and eight (3.9%) non-EBF infants presented
with clinical malaria (OR = 0.23; 95% CI = 0.01–1.78).
Among non-bed net users, all 12 cases of clinical malaria
recorded were among non-EBF infants. Stratification by bed
net use showed decreased odds of clinical malaria among
EBF infants (OR = 0.12; 95% CI = 0.00–0.79; Table 2). Simi-
lar results were obtained after stratification by use of anti-
malarial drugs (Table 2). Of 480 mothers, four with known
HIV statuses were HIV positive and only one infant with an
HIV-positive mother demonstrated malaria infection (zero cases
of clinical malaria).
DISCUSSION
The overall prevalence of malaria infection among the 495
6-month-old infants from Kinshasa, Democratic Republic of
TABLE 1
Association between maternal sociodemographic characteristics, use of bed nets, use of antimalarial drugs, and parasitemia or clinical malaria
status among the cohort of 495 Congolese infants at 24 weeks of age
Parasitemia* Clinical malaria†
Yes No P value‡ Yes No P value‡
Maternal age in years: median (IQR) 27.0 (21.0–30.0) 27.0 (23.0–33.0) 0.082 24.5 (20.5–28.5) 27.0 (23.0–33.0) 0.025
Maternal education in years: median (IQR) 9.0 (7.0–11.0) 10.0 (8.0–12.0) 0.108 9.0 (8.0–11.0) 10.0 (8.0–12.0) 0.109
Maternal marital status
Married/live-in boyfriend, n (%) 47 (10.8) 289 (89.2) 0.820 17 (3.9) 419 (96.1) 0.293
Never married/separated/divorced, n (%) 5 (8.6) 53 (91.4) 4 (6.9) 54 (93.1)
SES Quintile§
Fifth, n (%) 2 (2.0) 98 (98.0) 0.011 1 (1.0) 99 (99.0) 0.364
Fourth, n (%) 11 (11.2) 87 (88.8) 5 (5.1) 93 (94.9)
Third, n (%) 12 (12.5) 84 (87.5) 4 (4.2) 92 (95.8)
Second, n (%) 14 (14.4) 83 (85.6) 6 (6.2) 91 (93.8)
First, n (%) 13 (13.0) 87 (87.0) 5 (5.0) 95 (95.0)
Previous pregnancies
Yes, n (%) 11 (12.8) 75 (87.2) 0.441 4 (4.7) 82 (16.6) 0.772
No, n (%) 41 (10.0) 368 (90.0) 17 (4.2) 392 (95.8)
Use of bed nets
Yes, n (%) 28 (8.9) 287 (91.1) 0.129 9 (2.9) 306 (97.1) 0.061
No, n (%) 24 (13.3) 156 (86.7) 12 (6.7) 168 (93.3)
Use of antimalarial drugs
Yes, n (%) 9 (16.1) 47 (83.9) 0.164 9 (16.1) 47 (83.9) < 0.001
No, n (%) 43 (9.8) 396 (90.2) 12 (2.7) 427 (97.3)
IQR = interquartile range; SES = socioeconomic status.
*Malaria parasite detected in the blood using polymerase chain reaction.
†Parasitemia and report of any fever in the last month preceding the sample collection.
‡Using Fisher’s exact test or χ2 test for categorical variables and Wilcoxon rank sum test for continuous variables.
§SES quintiles score calculated using principle component analysis and 11 variables: home ownership, the average number of household members per room, water source, toilet facility type,
cooking fuel type, maternal education, and ownership status of durable assets (radio, television, mobile telephone, and refrigerator).
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the Congo, considered in this study was 10.5%. A concordance
of point estimates stratified by bed net use, reported fever,
and other factors suggested that EBF at 24 weeks was associ-
ated with lower odds of developing clinical malaria, although
only the findings of EBF protecting against fever among
infants with malaria infection and EBF reducing the odds of
clinical malaria were statistically significant.
This reduction in malaria susceptibility among EBF infants
may be related to the immunomodulatory effects of breast
milk.15 Previous studies that found a lack of an association
between EBF and malaria did not use PCR for malaria
detection, measured malaria infection in a broad interval
(age 3–12 months), and did not consider clinical malaria as
an outcome.
This cross-sectional study has several limitations, including
the small number of malaria cases, the unknown status of
genetic factors that affect disease susceptibility (i.e., hemo-
globinopathies), and the potential of recall bias. The issue
of recall bias and misclassification was attenuated in that
mothers and interviewers were blinded to the PCR results
during the interview. As a result, any misclassification
would be nondifferential and bias the association toward
the null. In addition, gravidity was not associated with
infection prevalence (Table 1), which suggests primigrav-
ida mothers were not subject to increased recall bias. This
lack of association between parity and malaria infection
prevalence may have resulted from the disproportionate
number of primigravida mothers in the study (82.6%). This
high number of primigravidae women in our study may limit
its generalizability.
Although it is unlikely that maternal breast milk IgG anti-
bodies are systemically absorbed into the circulation where
malaria parasites reside,16 EBF protected infants in this
study from developing clinical malaria. This observed effect
may be a byproduct of EBF reducing overall disease bur-
den,10,11 allowing for increased resource allocation to malaria
defenses, or the role of EBF in training and modulating
the infant’s immune system.15 It is possible that some of
the fever episodes among the malaria-infected children were
due to other etiologic agents. As such, our definition of clini-
cal malaria is lenient. In addition, antimalarial use was asso-
ciated with increased risk of malaria infection, possibly due
to detection of biologically inactive parasites. However, the
point estimates of both malaria infection and clinical malaria
in the presence and absence of bed nets suggest that EBF
has a protective effect. In addition, EBF reduced fever risk
among infants with malaria infection more than those with-
out a malaria infection (OR = 0.08 versus OR = 0.74, respec-
tively). Given these indications, our findings need to be
replicated in a larger prospective study.
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TABLE 2
Effect of exclusive breastfeeding on malaria infection and clinical malaria stratified by bed net use and use of antimalarial drugs
Parasitemia Odds ratio (95% CI)
EBF Yes No Crude Adjusted*
Bed net use
Yes Yes, n (%) 10 (9.3) 98 (90.7) 1.07 (0.42–2.56) 0.86 (0.41–1.71)
No, n (%) 18 (8.7) 189 (91.3)
No Yes, n (%) 3 (10.3) 26 (89.7) 0.71 (0.12–2.67)
No, n (%) 21 (13.9) 130 (86.1)
Use of antimalarial drugs
Yes Yes, n (%) 0 9 (100.0) NA 0.86 (0.41–1.71)
No, n (%) 9 (19.2) 38 (80.8)
No Yes, n (%) 13 (10.2) 115 (89.8) 1.06 (0.49–2.18)
No, n (%) 30 (9.7) 281 (90.3)
Clinical malaria
Bed net use
Yes Yes, n (%) 1 (0.9) 107 (99.1) 0.23 (0.01–1.78) 0.12 (0.00–0.79)
No, n (%) 8 (3.9) 199 (96.1)
No Yes, n (%) 0 29 (100.0) NA
No, n (%) 12 (7.9) 139 (92.1)
Use of antimalarial drugs
Yes Yes, n (%) 0 9 (100.0) NA 0.12 (0.00–0.79)
No, n (%) 9 (19.2) 38 (80.8)
No Yes, n (%) 1 (0.78) 127 (99.2) 0.21 (0.01–1.51)
No, n (%) 11 (3.5) 300 (96.5)
CI = confidence interval; EBF = exclusive breastfeeding; NA = not available.
*Cochran–Mantel–Haenszel common odds ratio controlling for the stratifying variable. The 95% CIs are exact CIs. Infants are first stratified by bed net use or antimalarial use, followed by
stratification by EBF status with respect to the outcomes of interest, parasitemia, and clinical malaria.
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